• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081234)   Today's Articles (1160)
For: Bellati G, Colloredo G, Roffi L, D'Aquino M, Bonino F, Idéo G. Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G. J Hepatol 1997;26:449-50. [PMID: 9059974 DOI: 10.1016/s0168-8278(97)80069-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Number Cited by Other Article(s)
1
Heathcote EJ, James S, Mullen KD, Hauser SC, Rosenblate H, Albert DG. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group. Hepatology 1999;30:562-6. [PMID: 10421669 DOI: 10.1002/hep.510300202] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
2
Deutschman CS. Acute-phase responses and SIRS/MODS: the good, the bad, and the nebulous. Crit Care Med 1998;26:1630-1. [PMID: 9781714 DOI: 10.1097/00003246-199810000-00007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
3
Roffi L, Colloredo G, Brugnetti B, Bellati G, Ricci A, Scalori A, Antonelli G, Panizzuti F, Pozzi M, Pioltelli P, Mancia G. HCV genotypes and breakthrough in patients treated with recombinant alpha interferon. Am J Gastroenterol 1998;93:1602-3. [PMID: 9732970 DOI: 10.1111/j.1572-0241.1998.01602.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
4
Leroy V, Baud M, de Traversay C, Maynard-Muet M, Lebon P, Zarski JP. Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C. J Hepatol 1998;28:375-81. [PMID: 9551673 DOI: 10.1016/s0168-8278(98)80309-7] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA